Page 1 | Search Results | Hematology, ASH Education Program

1-20 of 73

Sort by

Sort Order Select

Journal Articles

Novel agents and immune invasion in Hodgkin lymphoma

Reid W. Merryman, Ann LaCasce

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 243–248.

https://doi.org/10.1182/hematology.2019000029

Published: 2019

Journal Articles

Indolent lymphomas: pushing the pace with novel agents

Caron A. Jacobson

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 279–286.

https://doi.org/10.1182/hematology.2019000032

Published: 2019

Journal Articles

Myeloma: next generation immunotherapy

Adam D. Cohen

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 266–272.

https://doi.org/10.1182/hematology.2019000068

Published: 2019

Journal Articles

CAR T-cell therapy: is it prime time in myeloma?

Surbhi Sidana, Nina Shah

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 260–265.

https://doi.org/10.1182/hematology.2019000370

Published: 2019

Journal Articles

Mechanisms of and approaches to overcoming resistance to immunotherapy

Liora Schultz, Rebecca Gardner

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 226–232.

https://doi.org/10.1182/hematology.2019000018

Published: 2019

Journal Articles

Treatment of primary immunodeficiency with allogeneic transplant and gene therapy

Sung-Yun Pai

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 457–465.

https://doi.org/10.1182/hematology.2019000052

Published: 2019

Journal Articles

Moving immunotherapy into the front line in ALL

Amanda Winters, Lia Gore

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 209–217.

https://doi.org/10.1182/hematology.2019000017

Published: 2019

Journal Articles

Antibody-based therapies in patients with acute lymphoblastic leukemia

Shira Dinner, Michaela Liedtke

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 9–15.

https://doi.org/10.1182/asheducation-2018.1.9

Published: 2018

Journal Articles

Novel immunotherapy approaches to follicular lymphoma

Christopher R. Flowers, John P. Leonard, Loretta J. Nastoupil

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 194–199.

https://doi.org/10.1182/asheducation-2018.1.194

Published: 2018

Journal Articles

Are CAR T cells better than antibody or HCT therapy in B-ALL?

Michael A. Pulsipher

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 16–24.

https://doi.org/10.1182/asheducation-2018.1.16

Published: 2018

Journal Articles

Harnessing the power of the immune system in non-Hodgkin lymphoma: immunomodulators, checkpoint inhibitors, and beyond

Stephen M. Ansell

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 618–621.

https://doi.org/10.1182/asheducation-2017.1.618

Published: 2017

Journal Articles

Developing T-cell therapies for lymphoma without receptor engineering

Melanie Grant, Catherine M. Bollard

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 622–631.

https://doi.org/10.1182/asheducation-2017.1.622

Published: 2017

Journal Articles

Incorporation of nonchemotherapeutic agents in pediatric acute lymphoblastic leukemia

Lewis B. Silverman

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 259–264.

https://doi.org/10.1182/asheducation-2017.1.259

Published: 2017

Journal Articles

Cells to prevent/treat relapse following allogeneic stem cell transplantation

Andrew C. Dietz, Alan S. Wayne

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 708–715.

https://doi.org/10.1182/asheducation-2017.1.708

Published: 2017

Journal Articles

Graft versus tumor effects and why people relapse

J. H. Frederik Falkenburg, Inge Jedema

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 693–698.

https://doi.org/10.1182/asheducation-2017.1.693

Published: 2017

Journal Articles

Checkpoint inhibition and cellular immunotherapy in lymphoma

Premal Lulla, Helen E. Heslop

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 390–396.

https://doi.org/10.1182/asheducation-2016.1.390

Published: 2016

Journal Articles

Cellular immune responses in red blood cell alloimmunization

James C. Zimring, Krystalyn E. Hudson

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 452–456.

https://doi.org/10.1182/asheducation-2016.1.452

Published: 2016

Journal Articles

Immunoregulatory networks in sickle cell alloimmunization

Karina Yazdanbakhsh

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 457–461.

https://doi.org/10.1182/asheducation-2016.1.457

Published: 2016

Journal Articles

Cellular and vaccine immunotherapy for multiple myeloma

Alfred L. Garfall, Edward A. Stadtmauer

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 521–527.

https://doi.org/10.1182/asheducation-2016.1.521

Published: 2016

Journal Articles

Cytokine release syndrome with novel therapeutics for acute lymphoblastic leukemia

Noelle V. Frey, David L. Porter

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 567–572.

https://doi.org/10.1182/asheducation-2016.1.567

Published: 2016

NARROW

Novel agents and immune invasion in Hodgkin lymphoma

Indolent lymphomas: pushing the pace with novel agents

Myeloma: next generation immunotherapy

CAR T-cell therapy: is it prime time in myeloma?

Mechanisms of and approaches to overcoming resistance to immunotherapy

Treatment of primary immunodeficiency with allogeneic transplant and gene therapy

Moving immunotherapy into the front line in ALL

Antibody-based therapies in patients with acute lymphoblastic leukemia

Novel immunotherapy approaches to follicular lymphoma

Are CAR T cells better than antibody or HCT therapy in B-ALL?

Harnessing the power of the immune system in non-Hodgkin lymphoma: immunomodulators, checkpoint inhibitors, and beyond

Developing T-cell therapies for lymphoma without receptor engineering

Incorporation of nonchemotherapeutic agents in pediatric acute lymphoblastic leukemia

Cells to prevent/treat relapse following allogeneic stem cell transplantation

Graft versus tumor effects and why people relapse

Checkpoint inhibition and cellular immunotherapy in lymphoma

Cellular immune responses in red blood cell alloimmunization

Immunoregulatory networks in sickle cell alloimmunization

Cellular and vaccine immunotherapy for multiple myeloma

Cytokine release syndrome with novel therapeutics for acute lymphoblastic leukemia

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only